Taking Control Of Your Diabetes® - The Podcast!

Dexcom G7 Sensor, The 15-Day Sensor, and What to Expect from G8 with CEO Jake Leach

Taking Control Of Your Diabetes® - The Podcast!

Show Notes

Continuous glucose monitoring didn’t start as sleek apps and tiny sensors — it began with chunky receivers, short wear times, and a lot of skepticism. In this episode, Dr. Jeremy Pettus and Dr. Steve Edelman sit down with Dexcom CEO and original sensor engineer Jake Leach to trace the evolution of CGM from those early “Tylenol-shaped” receivers and repurposed pagers to today’s G7 system and beyond. They walk through the major turning points: abandoning long-term implants for subcutaneous sensors, proving that real-time CGM meaningfully improves time in range and safety, and pushing back against old-school thinking that insisted patients shouldn’t see their own data. From STS 3-Day to Seven Plus, G4, G5, G6, and now G7, Dr. Edelman, Dr. Pettus, and Jake Leach break down what each generation added — better accuracy, easier insertion, smartphone and cloud connectivity, and integration with pumps and AID systems. Most importantly, Dr. Edelman, Dr. Pettus, and Dexcom CEO Jake Leach, focus on what’s coming next and what it means for people living with diabetes today: the 15 day Dexcom G7 sensor, Smart Basal insulin titration for people with type 2 diabetes, AI-powered food logging, and the upcoming G8 platform designed to measure multiple analytes (glucose plus ketones and more) — all while pushing toward broader access and affordability. Key Topics: Early Dexcom Days & STS 3-Day: How Dexcom pivoted from implantable sensors to disposable subcutaneous CGMs and what the earliest systems were really like. Blinded vs Real-Time CGM: The ethics debate, safety implications, and studies proving real-time data improves time in range and reduces hypoglycemia. Seven Plus, G4 & G5: Major accuracy improvements, longer wear times, and the move to smartphone-based monitoring. G6 & Auto-Applicators: Eliminating mandatory calibrations and making sensor insertion faster and easier. G7 Wins & Growing Pains: Reduced size, faster warm-up, early reliability challenges, and how Dexcom addressed manufacturing and support issues. 15-Day Wear & Smart Basal: Extended wear life and CGM-guided basal insulin titration for type 2 diabetes. G8 & Multi-Analyte Sensing: A preview of Dexcom’s next-generation platform measuring glucose plus ketones and other markers. AI Food Logging & Smarter Care: Photo-based meal tracking and pairing nutrition data with glucose trends. Access & Affordability: Expanding CGM access globally and using data to reshape how diabetes care is delivered. 0:23 - Introduction & TCOYD’s 30th Anniversary 1:39 - Meet Jake Leach: 21 Years at Dexcom 3:08 - The Early Days: From Implantable Sensors to Patches 5:26 - The First Commercial CGM (STS 3-Day) & The "Pager" Receiver 8:35 - The Evolution to 7-Day Wear (Seven Plus) 10:15 - The Early Struggles with Insurance Coverage 12:32 - Why Unblinded Real-Time Data Changed Everything 16:36 - The G4 Era: Improved Accuracy & The "Share" Cradle 20:26 - G5: The Shift to Smartphone Connectivity 27:04 - Real Talk: Addressing G7 Connectivity & Sensor Failures 29:07 - Dexcom's "Unlimited Replacement" Policy for Failed Sensors 31:39 - CONFIRMED: The New 15-Day Sensor Launch 32:43 - "Smart Basal": A New Tool for Type 2 Diabetes 35:44 - G8 Reveal: Measuring Ketones, Lactate & Potassium 39:12 - New Feature: AI Smart Food Logging 41:22 - The Future of CGM: Pre-Diabetes & Heart Health 46:34 - Closing Thoughts ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources: Website: tcoyd.org Blog: tcoyd.org/blog Podcast: tcoydthepodcast.transistor.fm Instagram: / tcoyd Facebook: / tcoyd Stay connected! Sign up for our monthly newsletter here! Support TCOYD's educational programs: tcoyd.org/donate

★ Support this podcast ★

More from Taking Control Of Your Diabetes® - The Podcast!

Oct 8, 2026

What if you could take your basal insulin once a week instead of every day? Once-weekly basal insulin has arrived, offering a new approach that could make insulin therapy simpler while providing glucose control comparable to daily basal insulin. In this episode, Dr. Steve Edelman is joined by Dr. Athena Philis-Tsimikas, a leading diabetes researcher who has been directly involved in clinical trials of once-weekly basal insulins. Together, they explain how these ultra-long-acting insulins work, how a single injection can provide steady background insulin throughout an entire week, and what studies have shown when once-weekly insulin is compared with traditional daily basal insulin. The conversation gets practical with how once-weekly insulin is started, adjusted, and switched from daily basal insulin. Dr. Edelman and Dr. Philis-Tsimikas discuss the dosage differences with once-weekly basal insulin, how concentrated insulin keeps the actual injection volume small, and how fasting glucose can help guide dose adjustments. They also discuss what happens if you miss a dose and why reaching a steady state is an important part of understanding how these longer-acting insulins work. They also dive into the clinical trial results, including A1C, time in range, and hypoglycemia. In studies of people living with type 2 diabetes, once-weekly basal insulin provided similar A1C lowering to daily basal insulin without an increase in hypoglycemia. They also explain why the story is different for people living with type 1 diabetes, where studies found higher rates of hypoglycemia with weekly basal insulin, and what that means for its use in the United States. Finally, Dr. Edelman and Dr. Philis-Tsimikas look at how once-weekly insulin could make diabetes management easier. Going from seven basal injections a week to just one could help reduce some of the daily burden of diabetes and make it easier to consistently take your insulin. They also explore using weekly insulin alongside GLP-1 medications, potential combination therapies, cost and access, and what we still need to learn as these newer insulins move from clinical trials into everyday diabetes care. Key Topics: How once-weekly basal insulin works Once-weekly vs. daily basal insulin Starting, dosing, and adjusting weekly insulin Why weekly insulin doses may look surprisingly large A1C, time in range, and hypoglycemia results What to do if you miss a weekly dose Once-weekly insulin in type 1 vs. type 2 diabetes Who may benefit from once-weekly insulin? Reducing the burden of daily injections Using once-weekly insulin with GLP-1 medications Future insulin and GLP-1 combination therapies Cost, access, and real-world considerations What the future of basal insulin could look like This episode was supported by Lilly. ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

Sep 28, 2026

Managing type 2 diabetes can change over time, but having the right information for your patients can make those changes feel a lot more manageable. CGM can help your patients see what’s happening with their blood sugar and guide what comes next.

Sep 8, 2026

Chronic kidney disease (CKD) is one of the most common complications of diabetes, but here’s the tricky part: you can have it for years without feeling any symptoms. The good news? Kidney disease can often be detected early, and with the right screening, treatments, and lifestyle changes, its progression can be dramatically slowed. In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus are joined by nephrologist Dr. Bethany Karl to break down what everyone with diabetes should know about kidney health. Dr. E also steps into the patient seat to share his own experience living with chronic kidney disease, from discovering it without symptoms to navigating kidney tests and newer treatments. Together, they explain the two simple tests that can uncover kidney problems, why blood pressure and cardiovascular health matter, and how today’s growing toolbox of medications is giving people with diabetic kidney disease more reasons for hope.

Aug 25, 2026

Hot flashes, blood sugar swings, brain fog... is it menopause, diabetes, or both?

Aug 10, 2026

Have you or someone you know been diagnosed with type 2 diabetes, only to discover later it was actually type 1? You're not alone.

See all episodes →